Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery

SandboxAQ, an AI startup originating from Alphabet's Google and backed by Nvidia, has released a substantial dataset to accelerate drug discovery. Generated using Nvidia's chips, the 5.2 million synthetic three-dimensional molecules aim to predict drug-protein binding. This data, validated by real-world experiments, will train AI models, potentially revolutionising pharmaceutical research by virtually replicating lab results and saving time.